Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study, Blood, vol.113, pp.5412-5417, 2009. ,
Review of 1027 patients with newly diagnosed multiple myeloma, Mayo Clin. Proc, vol.78, pp.21-33, 2003. ,
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, Lancet Oncol, vol.15, pp.538-548, 2014. ,
Prevalence of monoclonal gammopathy of undetermined significance, N. Engl. J. Med, vol.354, pp.1362-1369, 2006. ,
Long-term follow-up of monoclonal gammopathy of undetermined significance, N. Engl. J. Med, vol.378, pp.241-249, 2018. ,
Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance, Leukemia, vol.28, pp.174-178, 2014. ,
Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies, Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czechoslov, vol.160, pp.305-309, 2016. ,
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma, Br. J. Haematol, vol.174, pp.127-135, 2016. ,
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders, Lancet Oncol, vol.20, pp.302-312, 2019. ,
Diagnosis of smoldering multiple myeloma, N. Engl. J. Med, vol.365, pp.474-475, 2011. ,
Serum free light chain ratio as a biomarker for highrisk smoldering multiple myeloma, Leukemia, vol.27, pp.941-946, 2013. ,
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma, J. Clin. Oncol, vol.28, pp.1606-1610, 2010. ,
The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma, Leukemia, vol.28, pp.2402-2403, 2014. ,
Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma, Ann. Hematol, vol.96, pp.1707-1714, 2017. ,
Positron Emission Tomography-Computed Tomography in the Diagnostic Evaluation of Smoldering Multiple Myeloma: Identification of Patients Needing Therapy, 2015. ,
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease, Leukemia, vol.30, pp.417-422, 2016. ,
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: A study of the International Myeloma Working Group, Blood Cancer J, vol.25, 2017. ,
Multidetector CT of the spine in multiple myeloma: Comparison with MR imaging and radiography, AJR Am. J. Roentgenol, vol.178, pp.1429-1436, 2002. ,
Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma, Eur. Radiol, vol.18, pp.51-58, 2008. ,
Baseline bone involvement in multiple myeloma-A prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucosepositron emission tomography in previously untreated patients, Haematologica, vol.101, pp.415-418, 2016. ,
Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey. Cancer Investig, vol.31, pp.206-211, 2013. ,